Intracytoplasmic Sperm Injection (icsi)
Intracytoplasmic sperm injection (ICSI) is a form of in vitro fertilization (IVF) in which a single sperm is injected directly into a mature egg so it can fertilize (MedlinePlus). ICSI is never done on its own: it is the fertilization step inside a full IVF cycle, and it is most often needed when the problem sits with the man's sperm, a low count, weak movement, abnormal shape, or very little usable sperm (Cleveland Clinic). If you are trying to conceive, or weighing treatment at home or abroad, this guide explains what ICSI involves, who it is for, what the treatment can do and what waiting can cost, and how to protect the woman, the embryo and your follow-up if you travel. One line matters more than anything else here: if a woman on a cycle develops severe or worsening abdominal pain, rapid weight gain or heavy bloating, shortness of breath, little or dark urine, a swollen or painful leg, fever, or heavy vaginal bleeding, she should get urgent local medical care now and not wait for a flight or the next cycle step (RCOG).
What ICSI is
ICSI is a type of IVF treatment. In ordinary IVF, a woman's egg and a man's sperm are joined outside the body in a laboratory dish, and fertilization is left to chance (MedlinePlus). In ICSI, the laboratory takes one sperm, draws it up into a very fine glass needle, and injects it straight into the centre of a mature egg (Manchester University NHS). From the couple's point of view, ICSI follows the same pathway as IVF; the only difference is how the egg is fertilized in the lab (UHCW NHS).
ICSI was introduced in 1992 to help fertilization when the sperm cannot penetrate the egg on its own, and it gives couples a route to a pregnancy even when very few sperm exist, since fertilization is possible as long as some sperm can be obtained (UHCW NHS; Manchester University NHS). In the United States it is now used in about six in ten assisted-reproduction cycles, typically when fertilization is likely to be reduced (ASRM).
ICSI sits inside the wider world of fertility treatment, where conventional IVF is the reference cycle and ICSI is its sperm-injection version. It has close siblings worth knowing: ICSI with IMSI magnifies and selects the most mobile sperm before injection; a frozen embryo transfer cycle is the later step where an embryo created by ICSI is thawed and placed; egg donation or egg donation with sperm donation comes in when a donor joins or replaces the partner's sperm; and embryo donation is an alternative path that uses a donated embryo rather than ICSI at all. The rest of the family couples weigh alongside it includes artificial insemination (donor), Clomid treatment, egg freezing and egg and ovarian cortex freezing, plus assisted laser hatching, embryo freezing and embryo, oocyte and sperm cryopreservation. The work that leads to ICSI runs through obstetrics and gynecology as a specialty, with the initial assessment via a consultation or check-up, tests read under diagnostics, follicle monitoring by radiology, and any embryo or genetic testing interpreted in pathology. When sperm must be collected surgically, or a uterine problem needs correcting, that belongs to surgery rather than the ICSI cycle.
How ICSI works
The basic steps of any IVF cycle are ovarian stimulation, egg retrieval, fertilization, embryo culture and embryo transfer, and ICSI replaces only the fertilization step (ASRM). Here is the order a couple walks through, and why each step exists.
It begins with an assessment of both partners, not just the woman. The man has a semen analysis, a simple test that checks sperm count and how well they move, because a treatable male factor is common and cheap to catch early (NHS). The woman is assessed for how her ovaries are likely to respond to stimulation, usually with hormone blood tests and ultrasound scans of her follicles and uterus (NHS). This step exists so the clinic can choose the right protocol and dose instead of starting blind.
Then comes the decision and consent conversation. The team explains the plan, the realistic odds for her age, the costs and the risks, and you agree before anything invasive happens (ASRM).
The woman then takes hormone injections for about eight to fourteen days to grow several eggs at once, monitored by transvaginal ultrasound and blood tests so the doctors know when the follicles are ready (ASRM). This stimulation is where the drugs act on her ovaries and where most of a cycle's medical risk sits (ASRM).
Egg retrieval is the surgical heart of the cycle. It is a minor operation called follicular aspiration, done under pain medication or a short anaesthetic, in which a thin needle guided by ultrasound passes through the vagina to collect the mature eggs (MedlinePlus; ASRM). Some women feel cramping afterward that eases by the next day (ASRM).
At the same time the man provides sperm, usually by ejaculation, or, for men with little or no sperm in the ejaculate, surgically from the testicle or epididymis (ASRM). The laboratory then performs ICSI: one chosen sperm is injected into each mature egg. This step can still damage eggs, an egg may fail to fertilize, or an embryo may stop growing (ASRM).
Any embryos that form are cultured for a few days and then transferred into the uterus in a quick procedure, with progesterone support afterward while the couple waits out the two-week wait for a pregnancy test. Surplus embryos can be frozen for a later transfer (ASRM).
Who it is for, and when not to wait
ICSI is the right tool when the problem is on the male side, or when a previous conventional IVF failed to fertilize the eggs. Doctors most often recommend it for a low sperm count, poor sperm quality or movement, a blockage in the male reproductive tract, or an inability to ejaculate (Cleveland Clinic; Manchester University NHS). It is also used when very few or no sperm can otherwise fertilize an egg, where it can be the only workable route (Manchester University NHS).
The reason not to wait is that the cause rarely fixes itself (WHO). Male infertility is most often a structural problem, a blocked tract or failing sperm production, and structural causes do not clear up on their own (WHO). Infertility itself is a recognized disease, and roughly one in six people of reproductive age worldwide experience it in their lifetime (WHO). The woman's fertility also declines with age, so a couple facing male-factor infertility loses time by putting a semen analysis off (NHS). The emotional toll of leaving it unresolved is real as well: infertility brings significant stress, anxiety and stigma, especially for women (WHO).
ICSI is not the default answer for every couple. If the main problem is on the woman's side, blocked tubes, ovarian or hormonal issues, or the cause is simply unexplained, a specialist will usually assess those first; overall, pregnancy and delivery rates with ICSI are similar to those with conventional IVF, so ICSI does not by itself improve outcomes (ASRM). And choosing not to pursue treatment, or choosing another route such as conventional IVF, donor sperm, or egg or embryo donation, is a legitimate decision, not a failure.
Two things should never wait for a planned trip. First, the semen analysis: more than eight in ten couples where the woman is under 40 conceive within a year of trying, and about half of those who do not conceive in the first year conceive in the second, but when the man has a low count or poor movement, waiting rarely helps and his partner's age keeps ticking (NHS). Second, during a cycle, the woman's warning signs for ovarian hyperstimulation or a retrieval complication, severe abdominal pain, rapid weight gain or bloating, shortness of breath, little or dark urine, a swollen or painful leg, fever or heavy bleeding, mean urgent local care now (RCOG).
How to prepare
Preparing well does not change the odds much, but it removes avoidable problems. Every item below has a reason.
- Do a fresh semen analysis and gather prior fertility results and scans: the clinic needs current numbers to choose the protocol and dose, and a treatable male factor is quick and cheap to catch (NHS).
- List current medications and supplements for both partners, so the clinic can adjust the plan and avoid conflicts with the stimulation drugs.
- Plan realistic time off and a stay for the woman: a full cycle spans injections and monitoring over about two weeks plus egg retrieval, the transfer, and the follow-up visits afterward if she becomes pregnant (ASRM).
- Arrange emotional support for both of you: the cycles are draining and the outcome is uncertain, so a person to confide in genuinely helps (WHO).
- If you are going abroad, get advice from a lawyer about legal parentage both at the destination and on returning home, because the rules differ by country (ASRM).
- Ask the clinic what its aftercare covers if something goes wrong during the cycle, and who pays for that care.
Writing your questions down before you meet the team helps you get the answers you need. You can ask:
- "For my partner's semen results, is ICSI the right step, or would conventional IVF do?"
- "Given my age, what are my realistic chances of a live birth per embryo transferred, and roughly how many cycles might that mean?"
- "If I develop ovarian hyperstimulation or a retrieval problem while abroad, how will you treat me, and who pays?"
- "What exactly does the package include, and what would emergency care cost me?"
- "Will you transfer one embryo, and how does that change my odds?"
What to expect, risks and recovery
ICSI's benefit is plain: it can create a pregnancy when the sperm cannot do it on their own, and when very few sperm exist it can be the only workable route to fertilization (Manchester University NHS). But it is not a guarantee. On average about 60 to 70 percent of injected eggs fertilize, and ICSI does not guarantee fertilization at all (UHCW NHS; Cleveland Clinic). Once fertilization does happen, the chance of a single baby or multiples is the same as with conventional IVF (ASRM).
What mainly decides whether a cycle ends in a baby is not the injection but the woman's age and the laboratory's skill. The Human Fertilisation and Embryology Authority measures success as live births per embryo transferred because that reflects what a clinic actually delivers (HFEA). A woman's response to the stimulation drugs declines with age, especially after 35, so more cycles can be cancelled for a low response (ASRM). Miscarriage after IVF also rises with age, from about 15 percent in the twenties to more than 50 percent in the forties (ASRM).
The medical concerns sit mostly on the woman's side, because the invasive steps are her stimulation and her egg retrieval. The injection itself carries fewer risks than the woman's stimulation and retrieval, but the needle can still damage an egg, an egg may not fertilize, and an embryo may stop developing (Cleveland Clinic).
- Egg-retrieval problems: the retrieval needle can, rarely, injure nearby organs such as the bladder, bowel or a blood vessel, and very rarely this needs emergency surgery or a blood transfusion (ASRM). Bleeding and infection are the more common retrieval problems; a pelvic infection after retrieval or transfer is uncommon but can require hospitalization and intravenous antibiotics (ASRM).
- Ovarian hyperstimulation syndrome (OHSS): the stimulation drugs can push the ovaries too far. Mild OHSS is common, affecting about 33 percent of women, but just over 1 in 100 develop moderate or severe OHSS (RCOG). Severe OHSS brings extreme thirst and dehydration, little dark urine, difficulty breathing from fluid in the chest, and rarely blood clots or kidney failure (RCOG; ASRM).
- Multiple pregnancy: transferring more than one embryo raises the risk of twins or triplets, which carries significant risks such as preterm delivery, severe bleeding, high blood pressure, gestational diabetes and delivery by caesarean; the more embryos transferred, the greater the risk, which is why clinics increasingly transfer just one (ASRM).
- The lab-stage limits: the needle can damage eggs, an egg may fail to fertilize, or an embryo may stop developing (Cleveland Clinic; ASRM).
- Rare child-related associations: a small number of conditions have been linked to ICSI, including Beckwith-Wiedemann syndrome, Angelman syndrome, hypospadias and sex-chromosome abnormalities, though these are thought to occur in less than 1 percent of children conceived using ICSI and it is unclear whether the technique or the underlying infertility causes them (ASRM).
The risks of treatment and the risks of waiting. The treatment risks above are real, and repeated cycles are expensive and emotionally draining (WHO). But waiting has its own costs, and for male-factor infertility those costs are mostly time, not comfort: a blocked sperm tract or failing sperm production does not clear up on its own (WHO), and the woman's fertility keeps falling with age, so a delay can shrink what options remain (NHS). Infertility is a disease, and roughly one in six people of reproductive age worldwide live with it at some point (WHO). The cycles can fail and the drugs carry downsides of their own, and ignoring the problem wastes the woman's time and the couple's emotional energy. The point is to decide with both eyes open.
Recovery on the surface is quick: most women are back to normal within a day or two of egg retrieval (ASRM). But recovery is not only physical. The two-week wait after transfer is hard, and a negative test means deciding whether to try again. What is known is that ICSI does not guarantee a baby; what is not known for a given couple is how many cycles it will take.
Finding ICSI abroad on MTR
Abroad, the legal and logistical layer matters as much as the clinical one. People travel for fertility care for four basic reasons: access, cost, regulation, and privacy or cultural comfort (ASRM). A few of those reasons are specific to ICSI.
- Legal parentage and donor rules first. The destination's law decides who counts as a legal parent, whether donor anonymity exists, and who may even access treatment. In some Middle Eastern countries only opposite-sex married couples have access to reproductive care (ASRM). Rules requiring donor identity affect the supply of donors too, and donor anonymity cannot be guaranteed anywhere, because genetic testing can later reveal identity (ASRM). Get advice from a lawyer about parentage both at the destination and back home before you book (ASRM).
- An accredited facility for the retrieval. Egg retrieval is a surgical step done under anaesthetic, so confirm the clinic can handle the rare retrieval injury that needs emergency surgery or a blood transfusion (ASRM).
- Aftercare and who pays. Agree in writing who treats the woman if OHSS or a clot arises far from home, and who pays for that care.
- Flying and clot risk. Long-distance flights raise the risk of a blood clot by two to four times, which matters if you fly home mid-cycle or while still on stimulation (CDC). Ask your clinic when flying is appropriate for your specific cycle rather than relying on a fixed rule.
- Insurance that covers assisted reproduction. Check whether your policy covers a fertility cycle and its follow-up, as coverage varies.
- English records. Ask for your full cycle records in English so a doctor at home can take over follow-up.
You can compare providers offering this treatment in the directory of ICSI providers abroad, and read MTR's guides on top medical tourism destinations worldwide and U.S. medical tourism.
This week, book the semen analysis and the fertility assessment, gather any prior results and scans, and write down your questions, including which of them you need answered before choosing a destination.
Medical disclaimer: This information is for general educational purposes and is not medical advice. Always consult a qualified healthcare professional about your individual situation.
Reviewed against authoritative medical sources (MedlinePlus, the US National Library of Medicine; the National Health Service of England; the World Health Organization; the American Society for Reproductive Medicine; the Cleveland Clinic; the Royal College of Obstetricians and Gynaecologists; the Human Fertilisation and Embryology Authority; the US Centers for Disease Control and Prevention).
Last reviewed: 18 November 2026
Providers that provide Intracytoplasmic Sperm Injection (icsi) Service
| Providers | Score | Reviews | Location |
|---|---|---|---|
| Fertility Argentina |
98.02 |
52 | Argentina |
| Gryshchenko Clinic - IVF (GC-IVF) |
94.31 |
8 | Ukraine |
| ISIDA-IVF Clinic |
92.65 |
14 | Ukraine |
| Feskov Human Reproduction Group |
88.32 |
6 | Ukraine |
| Sellmer Klinik |
63 |
1 | Denmark |
| Clinica Eugin |
60.17 |
1 | Spain |
| Ovoclinic |
60.17 |
1 | Spain |
| EuroCARE IVF Clinic |
50.57 |
2 | Cyprus |
| Vithas Xanit International Hospital |
50.52 |
7 | Spain |
| Baskent University Hospitals |
Not Rated |
0 | Turkey |
| California Fertility Partners |
Not Rated |
0 | United States |
| Dr. Neelu Test Tube Baby Center In Punjab |
Not Rated |
0 | India |
| Femiint Fertility |
Not Rated |
0 | India |
| Genesis Fertility Center |
Not Rated |
0 | Greece, Thailand |
| Health and Beauty Turkey |
Not Rated |
0 | Turkey |
| Hegde Fertility Centre |
Not Rated |
0 | India |
| Indira Infertility & Test Tube Baby Centre |
Not Rated |
0 | India |
| Indraprastha Apollo Hospitals Delhi |
Not Rated |
0 | India |
| Medicana Ivf Center Istanbul |
Not Rated |
0 | Turkey |
| MINI IVF CENTER |
Not Rated |
0 | Ukraine |
